Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 18021-18022 [05-7014]

Download as PDF Federal Register / Vol. 70, No. 67 / Friday, April 8, 2005 / Notices 18021 III. 49 NOTICES OF COMMENCEMENT FROM: 02/21/05 TO 03/15/05—Continued Case No. Commencement Notice End Date Received Date P–04–0751 03/09/05 02/10/05 P–04–0763 03/01/05 02/10/05 P–04–0764 03/01/05 02/10/05 P–04–0797 P–04–0802 P–04–0817 P–04–0818 P–04–0832 P–04–0839 P–04–0840 P–04–0841 P–04–0842 P–04–0843 P–04–0872 P–04–0877 P–04–0879 P–04–0911 P–04–0960 P–05–0040 P–05–0066 P–05–0071 P–05–0077 02/22/05 02/23/05 03/04/05 03/10/05 02/23/05 02/25/05 02/25/05 02/25/05 02/25/05 02/25/05 02/23/05 03/15/05 02/23/05 02/24/05 03/11/05 03/04/05 02/23/05 03/10/05 02/23/05 01/28/05 02/08/05 02/23/05 02/23/05 02/11/05 02/08/05 02/11/05 02/14/05 02/08/05 02/11/05 01/25/05 03/04/05 01/24/05 01/24/05 02/14/05 01/24/05 02/16/05 02/16/05 02/18/05 P–05–0103 P–05–0111 02/22/05 02/25/05 02/07/05 02/22/05 P–05–0113 02/25/05 02/22/05 P–95–0482 03/15/05 02/23/05 List of Subjects Environmental protection, Chemicals, Premanufacturer notices. Dated: March 30, 2005. Vicki A. Simons, Acting Director, Information Management Division, Office of Pollution Prevention and Toxics. [FR Doc. 05–6854 Filed 4–7–05; 8:45 am] BILLING CODE 6560–50–S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies VerDate jul<14>2003 19:00 Apr 07, 2005 Jkt 205001 Chemical (G) Alkanedioic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 1,3-isobenzofurandione and 2-methyl-1,3-propanediol, 2-hydroxy-3-[(1oxoneodecyl)oxy]propyl ester (G) Polycarboxylate polymer with alkenyloxyalkylol modified poly(oxyalkylenediyl), calcium sodium salt (G) Polycarboxylate polymer with alkenyloxyalkylol modified poly(oxyalkylenediyl), sodium salt (G) Poly acrylic dispersion peroxide initiated poly acrylic esters with amine salt. (G) Isocyanate terminated urethane polymer (G) Trimethyl acyclic alkenones (G) Urethane acrylate (S) Bicyclo[2.2.1]heptan-2-ol, 2-ethyl-1,3,3-trimethyl(G) Copolymer of acrylic acid and maleic acid (G) Copolymer of maleic acid and styrene (G) Copolymer of maleic acid and styrene (G) Copolymer of maleic acid and styrene (G) Copolymer of acrylic acid and styrene (G) Aromatic polyester polyurethane prepolymer based on mdi (G) Substituted ppvs (poly-p-phenylen-vinylens) (G) C11–17 hydrocarbons (G) Aryl-substituted diether propane (G) Biphenyl-bis(azo-acetoaceto-benzoate) (G) Modified starch-acrylate polymer (G) Polyester polyurethane (G) Telechelic polyacrylates (S) Siloxanes and silicones, di-methyl, 3-hydroxypropyl methyl, ethers with polyethylene glycol and polyethylene glycol mono(2-carboxyethyl) ether, polymers with 1,1′-methylenebis[4-isocyanatocyclohexane] (G) Halo phenyl amino substituted cyclohexene salt (G) Toluylenediisocyanate, reaction product with benzenedimethanamine and methoxypolyethylene glycol (G) Polyethylene-polypropylene glycol, reaction product with octadecylisocyanate (G) Condensation polyester of glycols and diacids owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 2, 2005. A. Federal Reserve Bank of Philadelphia (Michael E. Collins, Senior PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Vice President) 100 North 6th Street, Philadelphia, Pennsylvania 19105-1521: 1. North Penn Mutual Holding Company and North Penn Bancorp, both of Scranton, Pennsylvania; to become bank holding companies by acquiring 100 percent of the of the voting shares of North Penn Bank, Scranton, Pennsylvania. B. Federal Reserve Bank of Richmond (A. Linwood Gill, III, Vice President) 701 East Byrd Street, Richmond, Virginia 23261-4528: 1. Premier Community Bankshares, Inc., Winchester, Virginia; to acquire 100 percent of the voting shares of Premier Bank, Inc., Martinsburg, West Virginia (in organization). C. Federal Reserve Bank of San Francisco (Tracy Basinger, Director, Regional and Community Bank Group) 101 Market Street, San Francisco, California 94105-1579: 1. Oakland Venture Group, Los Angeles, California; to become a bank holding company by acquiring 100 percent of the voting shares of Innovative Bancorp, and thereby indirectly acquire Innovative Bank, both of Oakland, California. E:\FR\FM\08APN1.SGM 08APN1 18022 Federal Register / Vol. 70, No. 67 / Friday, April 8, 2005 / Notices Board of Governors of the Federal Reserve System, April 4, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–7014 Filed 4–7–05; 8:45 am] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Linkage of International Collaboration and Research Programs for Prevention and Control of Malaria Announcement Type: New. Funding Opportunity Number: RFA CI05–062. Catalog of Federal Domestic Assistance Number: 93.283. Application Deadline: May 23, 2005. I. Funding Opportunity Description Authority: 42 U.S.C. 241(a); 42 U.S.C. 2421. Background Burden of malaria in Africa and Asia: Each year, malaria causes an estimated 500 million infections and more than one million deaths. The main risk groups in highly endemic areas, such as in most of sub-Saharan Africa, are children less than five years of age and pregnant women. Malaria drains economies in Africa, Asia, and the Americas—causing a loss of up to six percent of Gross National Product (GNP) from lost productivity and health service costs, with over 50 percent of the world’s population at risk for malaria. Thus, prevention of malaria and, when it occurs, its effective treatment, are high public health priorities in endemic countries. There is a paucity of data on the burden of malaria from Asia. Malaria control: Three major tools are currently used to control malaria: preventing and treating disease with drugs, reducing human-vector contact such as by insecticide treated mosquito nets (ITNs), and controlling mosquitoes (e.g. spraying of insecticides). The use of drugs for treatment and prevention remains one of the main pillars for the Roll Back Malaria initiative (RBM), but the rampant spread of drug resistance of the malaria parasite to the cheap and most commonly available antimalarials is a major problem. Nevertheless, drug development has improved considerably in the last five years and the outlook for new antimalarials is now better than it has been for decades. VerDate jul<14>2003 19:00 Apr 07, 2005 Jkt 205001 Much needs to be done to test their safety and efficacy and further work is needed to ensure that they are optimally used and made accessible to the target population. Reduction of human-vector contact by use of ITNs has been shown to reduce under-five mortality by 18 percent in Africa and ITNs are now one of the main RBM strategies. Despite the clear evidence of their efficacy in Africa, very little is known about their impact in Asia. In some regions of Asia the vector bites early in the evening or morning thus ITNs may not be the optimal prevention tool and other methods that reduce human-vector contact should be explored, including DEET retaining repellents. Vector control has saved millions of lives worldwide and indoor residual spraying with insecticides (IRS) continues to play a major role in much of Latin America and Asia, but its cost, logistical complexity and moderate efficacy made it poorly suited for rural areas of sub-Saharan Africa. Nevertheless advances in genomics (including the mapping of the mosquito and parasite genome), biotechnology, and mapping using geographical information systems, present exiting new opportunities for the development and employment of more cost-effective tools that take aim at the mosquito. Global collaboration: Although important progress in malaria control has been accomplished in recent years, much more could have been done. This slow progress is partly due to the lack of funding. CDC recognizes that this is also due to lack of coordination between research groups, and between researchers and donors, policy makers, and Government Ministries responsible for implementation. After decades of neglect the international community is showing a renewed interest in controlling malaria. This has resulted in new initiatives, including the RBM initiative, Global Fund Initiative (GFATM) and Malaria Vaccine Initiative as well as significant new funding for both research and program development. Global collaboration is now more critical than ever to ensure translation of this commitment into action and avoid fragmentation of efforts. Many of these studies require well-coordinated multi-center trials to allow rapid accumulation of data and account for the geographical variations in drug sensitivity, frequency of hostgenetic polymorphism, cultural preferences and economics. Purpose The purpose of this program is to strengthen international collaborative PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 efforts with leading European Institutions to expedite the identification, evaluation and implementation of malaria control strategies in sub-Saharan Africa and Asia. The aim is to move forward the RBM agenda of increasing access to case management and preventive interventions against malaria by promoting work in a complementary way on key issues relevant to the control of malaria. CDC is committed to achieving the health promotion and disease prevention objectives of ‘‘Healthy People 2010’’, a national activity to reduce morbidity and mortality and improve the quality of life. This announcement addresses the ‘‘Healthy People 2010’’ focus areas of HIV, Immunization, Infectious Diseases and Public Health Infrastructure. For the conference copy of ‘‘Healthy People 2010’’, visit the Internet site https:// www.health.gov/healthy-people. Measurable outcomes of the program will be in alignment with one (or more) of the National Center for Infectious Disease (NCID) priority areas identified in ‘‘Protecting the Nation’s Health in an Era of Globalization: CDC’s Global Strategy for Addressing Infectious Diseases’’. Priority areas for this cooperative agreement include: (1) Applied research on diseases of global importance, (2) application of proven public health tools, (3) global initiatives for disease control and, (4) public health training and capacity building. Research Objectives • Nature of the research problem. Burden and control of malaria in India: Conventional estimates of the global burden of malaria suggest that over 90 percent of the burden occurs in Africa. There is however a paucity of reliable data from Asia, particularly India, which has a population of 1 billion, more than the entire African continent. India’s National Vector Borne Disease Control Programme reports less than two million cases annually, but recent estimates from the World Health Organization (WHO) suggest this may be as high as 45–100 million. Although transmission is lower than in Africa, less malarial immunity is acquired during a lifetime of exposure so that even adults remain at risk of dying from severe malaria. Establishment of more accurate estimates of the burden of malaria, and appropriate evidencedbased treatment and prevention policies are essential to minimizing this public health threat of malaria in India. ITNs and IRS alone can reduce malaria transmission by as much as 90 percent. Despite this, a significant E:\FR\FM\08APN1.SGM 08APN1

Agencies

[Federal Register Volume 70, Number 67 (Friday, April 8, 2005)]
[Notices]
[Pages 18021-18022]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7014]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The applications listed below, as well as other related filings 
required by the Board, are available for immediate inspection at the 
Federal Reserve Bank indicated. The application also will be available 
for inspection at the offices of the Board of Governors. Interested 
persons may express their views in writing on the standards enumerated 
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the 
acquisition of a nonbanking company, the review also includes whether 
the acquisition of the nonbanking company complies with the standards 
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, 
nonbanking activities will be conducted throughout the United States. 
Additional information on all bank holding companies may be obtained 
from the National Information Center website at www.ffiec.gov/nic/.
    Unless otherwise noted, comments regarding each of these 
applications must be received at the Reserve Bank indicated or the 
offices of the Board of Governors not later than May 2, 2005.
    A. Federal Reserve Bank of Philadelphia (Michael E. Collins, Senior 
Vice President) 100 North 6th Street, Philadelphia, Pennsylvania 19105-
1521:
    1. North Penn Mutual Holding Company and North Penn Bancorp, both 
of Scranton, Pennsylvania; to become bank holding companies by 
acquiring 100 percent of the of the voting shares of North Penn Bank, 
Scranton, Pennsylvania.
    B. Federal Reserve Bank of Richmond (A. Linwood Gill, III, Vice 
President) 701 East Byrd Street, Richmond, Virginia 23261-4528:
    1. Premier Community Bankshares, Inc., Winchester, Virginia; to 
acquire 100 percent of the voting shares of Premier Bank, Inc., 
Martinsburg, West Virginia (in organization).
    C. Federal Reserve Bank of San Francisco (Tracy Basinger, Director, 
Regional and Community Bank Group) 101 Market Street, San Francisco, 
California 94105-1579:
    1. Oakland Venture Group, Los Angeles, California; to become a bank 
holding company by acquiring 100 percent of the voting shares of 
Innovative Bancorp, and thereby indirectly acquire Innovative Bank, 
both of Oakland, California.


[[Page 18022]]


    Board of Governors of the Federal Reserve System, April 4, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05-7014 Filed 4-7-05; 8:45 am]
BILLING CODE 6210-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.